Metastatic Adenocarcinoma of the Pancreas
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB09074 | Olaparib | A poly (ADP-ribose) polymerase (PARP) inhibitor used to treat ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00126 | Ascorbic acid | 1 | Terminated | 1 |
| DB00441 | Gemcitabine | 1 | Terminated | 1 |
| DB17309 | Minnelide | 1 | Recruiting | 1 |
| DB01101 | Capecitabine | 2 | Completed | 1 |
| DB00530 | Erlotinib | 2 | Completed | 1 |
| DB00544 | Fluorouracil | 2 | Not Yet Recruiting | 1 |
| DB00441 | Gemcitabine | 2 | Unknown Status | 1 |
| DB00762 | Irinotecan | 2 | Not Yet Recruiting | 1 |
| DB00650 | Leucovorin | 2 | Not Yet Recruiting | 1 |
| DB00526 | Oxaliplatin | 2 | Not Yet Recruiting | 1 |
| DB01229 | Paclitaxel | 2 | Unknown Status | 1 |
| DB00544 | Fluorouracil | 3 | Active Not Recruiting | 1 |
| DB00441 | Gemcitabine | 3 | Active Not Recruiting | 1 |
| DB00762 | Irinotecan | 3 | Active Not Recruiting | 1 |
| DB00650 | Leucovorin | 3 | Active Not Recruiting | 1 |
| DB09074 | Olaparib | 3 | Completed | 1 |
| DB00526 | Oxaliplatin | 3 | Active Not Recruiting | 1 |
| DB01229 | Paclitaxel | 3 | Active Not Recruiting | 1 |